Markus J. Cappel insider trades: ChemoCentryx (CCXI) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Markus reports to the SEC
Open-market buys and sales
51 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | CCXI | ↓ Sell | 7,564 | $50.22 | $380K | Direct | Aug 8, 2022 (4d) |
| Mar 1, 2021 | CCXI | ↓ Sell | 33,092 | $68.43 | $2.3M | Direct | Mar 3, 2021 (2d) |
| Feb 9, 2021 | CCXI | ↓ Sell | 700 | $69.66 | $49K | Direct | Feb 11, 2021 (2d) |
| Feb 8, 2021 | CCXI | ↓ Sell | 9,625 | $67.26 | $647K | Direct | Feb 8, 2021 (0d) |
| Jan 25, 2021 | CCXI | ↓ Sell | 1,375 | $67.03 | $92K | Direct | Jan 27, 2021 (2d) |
| Jun 12, 2020 | CCXI | ↓ Sell | 33,541 | $65.10 | $2.2M | Direct | Jun 16, 2020 (4d) |
| May 26, 2020 | CCXI | ↓ Sell | 63,279 | $60.15 | $3.8M | Direct | May 26, 2020 (0d) |
| May 11, 2020 | CCXI | ↓ Sell | 38,534 | $54.54 | $2.1M | Direct | May 12, 2020 (1d) |
| May 5, 2020 | CCXI | ↓ Sell | 8,860 | $55.01 | $487K | Direct | May 7, 2020 (2d) |
| Feb 19, 2020 | CCXI | ↓ Sell | 42,631 | $50.36 | $2.1M | Direct | Feb 21, 2020 (2d) |
| Feb 6, 2020 | CCXI | ↓ Sell | 36,850 | $47.31 | $1.7M | Direct | Feb 10, 2020 (4d) |
| Feb 5, 2020 | CCXI | ↓ Sell | 61,621 | $45.02 | $2.8M | Direct | Feb 5, 2020 (0d) |
| Jan 21, 2020 | CCXI | ↓ Sell | 1,259 | $44.00 | $55K | Direct | Jan 23, 2020 (2d) |
| Jan 16, 2020 | CCXI | ↓ Sell | 50,000 | $40.07 | $2.0M | Direct | Jan 17, 2020 (1d) |
| Jan 14, 2020 | CCXI | ↓ Sell | 116,456 | $37.27 | $4.3M | Direct | Jan 15, 2020 (1d) |
| Nov 26, 2019 | CCXI | ↓ Sell | 330,524 | $32.03 | $10.6M | Direct | Nov 27, 2019 (1d) |
| Jan 10, 2019 | CCXI | ↓ Sell10b5-1 | 6,172 | $12.00 | $74K | Direct | Jan 14, 2019 (4d) |
| Jan 9, 2019 | CCXI | ↓ Sell10b5-1 | 13,203 | $12.03 | $159K | Direct | Jan 9, 2019 (0d) |
| Oct 26, 2018 | CCXI | ↓ Sell10b5-1 | 30,237 | $11.01 | $333K | Direct | Oct 30, 2018 (4d) |
| Jun 29, 2018 | CCXI | ↓ Sell10b5-1 | 25,179 | $13.67 | $344K | Direct | Jun 29, 2018 (0d) |
| May 21, 2018 | CCXI | ↓ Sell10b5-1 | 2,709 | $13.00 | $35K | Direct | May 23, 2018 (2d) |
| May 16, 2018 | CCXI | ↓ Sell10b5-1 | 33,334 | $11.84 | $395K | Direct | May 17, 2018 (1d) |
| May 16, 2018 | CCXI | ↓ Sell10b5-1 | 16,666 | $11.75 | $196K | Direct | May 17, 2018 (1d) |
| May 2, 2018 | CCXI | ↓ Sell10b5-1 | 50,000 | $11.02 | $551K | Direct | May 3, 2018 (1d) |
| Jan 3, 2017 | CCXI | ↓ Sell | 26,821 | $7.51 | $201K | Direct | Jan 4, 2017 (1d) |
| Mar 9, 2015 | CCXI | ↓ Sell | 34,125 | $7.81 | $267K | Direct | Mar 9, 2015 (0d) |
| Mar 4, 2015 | CCXI | ↓ Sell | 40,875 | $7.98 | $326K | Direct | Mar 4, 2015 (0d) |
| Apr 22, 2014 | CCXI | ↓ Sell | 20,962 | $8.17 | $171K | Direct | Apr 24, 2014 (2d) |
| Aug 13, 2013 | CCXI | ↓ Sell | 5,459 | $12.90 | $70K | Direct | Aug 14, 2013 (1d) |
| Aug 1, 2013 | CCXI | ↓ Sell | 6,250 | $13.82 | $86K | Direct | Aug 5, 2013 (4d) |
| Jul 17, 2013 | CCXI | ↓ Sell | 5,459 | $14.52 | $79K | Direct | Jul 19, 2013 (2d) |
| Jul 2, 2013 | CCXI | ↓ Sell | 6,250 | $13.88 | $87K | Direct | Jul 3, 2013 (1d) |
| Jun 21, 2013 | CCXI | ↓ Sell | 6,250 | $13.00 | $81K | Direct | Jun 25, 2013 (4d) |
| Jun 18, 2013 | CCXI | ↓ Sell | 1,783 | $12.47 | $22K | Direct | Jun 20, 2013 (2d) |
| May 28, 2013 | CCXI | ↓ Sell | 3,676 | $14.10 | $52K | Direct | May 29, 2013 (1d) |
| May 15, 2013 | CCXI | ↓ Sell | 15,668 | $14.08 | $221K | Direct | May 17, 2013 (2d) |
| Apr 11, 2013 | CCXI | ↓ Sell | 1,500 | $14.10 | $21K | Direct | Apr 12, 2013 (1d) |
| Apr 3, 2013 | CCXI | ↓ Sell | 6,250 | $13.47 | $84K | Direct | Apr 5, 2013 (2d) |
| Mar 19, 2013 | CCXI | ↓ Sell | 5,059 | $13.96 | $71K | Direct | Mar 19, 2013 (0d) |
| Mar 11, 2013 | CCXI | ↓ Sell | 400 | $14.15 | $6K | Direct | Mar 13, 2013 (2d) |
| Feb 28, 2013 | CCXI | ↓ Sell | 25,000 | $13.22 | $331K | Direct | Mar 1, 2013 (1d) |
| Feb 13, 2013 | CCXI | ↓ Sell | 5,459 | $11.45 | $62K | Direct | Feb 14, 2013 (1d) |
| Jan 18, 2013 | CCXI | ↓ Sell | 2,759 | $11.16 | $31K | Direct | Jan 22, 2013 (4d) |
| Jan 17, 2013 | CCXI | ↓ Sell | 2,700 | $11.16 | $30K | Direct | Jan 17, 2013 (0d) |
| Dec 18, 2012 | CCXI | ↓ Sell | 4,843 | $10.94 | $53K | Direct | Dec 20, 2012 (2d) |
| Nov 26, 2012 | CCXI | ↓ Sell | 201 | $12.10 | $2K | Direct | Nov 28, 2012 (2d) |
| Nov 23, 2012 | CCXI | ↓ Sell | 2,188 | $11.94 | $26K | Direct | Nov 26, 2012 (3d) |
| Nov 20, 2012 | CCXI | ↓ Sell | 10 | $12.10 | $121 | Direct | Nov 21, 2012 (1d) |
| Nov 6, 2012 | CCXI | ↓ Sell | 3,676 | $12.10 | $44K | Direct | Nov 8, 2012 (2d) |
| Oct 22, 2012 | CCXI | ↓ Sell | 10,918 | $10.87 | $119K | Direct | Oct 22, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Markus J. Cappel's insider trades
Markus J. Cappel is Chief Bus. Officer & Treasurer at ChemoCentryx (CCXI). Since Sep 25, 2012, Markus has reported no open-market purchases and 51 sales worth $40.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
8 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (50 filings), grants and awards (12 filings), shares withheld for taxes (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CCXI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.